All | Nanosphere

All News (5)
Press Releases (2)
In The News (3)
Upcoming Events (3)
Past Events (9)

Nanosphere Receives FDA Clearance of Gram-Positive Blood Culture Test for Staphylococcus

DECEMBER 27, 2011

Nanosphere announced it has received FDA clearance for its Staphylococcus Blood Culture Nucleic Acid Test (BC-S) on the automated sample-to-result Verigene System.

Nanosphere Obtains CE Mark for Gram-Positive Blood Culture Test

DECEMBER 19, 2011

Nanosphere announced it has obtained CE IVD Mark under the European Directive on In Vitro Diagnostic Medical Devices for its Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) on the automated sample-to-result Verigene System.

TARGET-PCI trial to assess value of genetic & platelet function testing

SEPTEMBER 7, 2011

Article summary
A new clinical trial enrolling 1,500 patients will assess the efficacy of using genetic and platelet function tests to identify individual patient risk of developing a cardiac event after a coronary stenting procedure.

Nanotechnology PSA Measurements Predict Prostate Cancer Recurrence, Quality Response to Adjuvant Therapy After Surgical Treatment

SEPTEMBER 7, 2011

A nanotechnology-enabled prostate-specific antigen (PSA) test [Verisens™ PSA (RUO), Nanosphere, Inc.], 300 times more sensitive than conventional commercial tests, may be valuable in stratifying recurrence risk and monitoring a man’s response to adjuvant therapy following radical prostatectomy, according to new data from Northwestern University (NU).

Nanosphere Featured on PBS' NOVA: "Making Stuff: Smaller"

SEPTEMBER 7, 2011

Nanosphere is featured in the January 26^th 2011 airing of the Nova series "Making Stuff Smaller" starting at about 43 mintues into the show.